Big players in the Alzheimer’s drug market

| | Health Imaging | Neuroimaging

A new drug to treat Alzheimer’s disease would obviously impact the lives of millions of people in the U.S. affected by the disease. Any significant breakthrough could also mean tens of billions of dollars for the pharmaceutical company that makes it.

Recently, a panel on CNBC discussed the companies currently working on drugs designed to break up amyloid plaques associated with Alzheimer’s and where the research stands:

Visit NBCNews.com for breaking news, world news, and news about the economy

Via CNBC

Related Content

Experts update AUC for amyloid, tau PET imaging for first time in more than a decade
Infamous kidnapping survivor shares brain scan findings detailing the impact of her trauma
New algorithm is twice as accurate at predicting stroke timing compared to the standard of care
How gaming addiction affects brain activity, according to new MRI data
How opioid use disorder affects brain size and function
Radiomics model links brain MRI features with neuropsychological changes in Crohn's disease

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.